Medically reviewed by Erika Prouty, PharmD Key Takeaways Always ask your healthcare provider before starting a new supplement if you are on prescription medications.Some supplements can reduce the ...

Xadago (safinamide) is a brand-name oral tablet that’s prescribed for Parkinson’s disease. Xadago has interactions with alcohol, some other drugs, and certain supplements. Examples include opioids and ...

Duopa (carbidopa/levodopa) is a prescription drug used to treat motor fluctuations in adults with advanced Parkinson’s disease. Duopa can interact with other medications and some supplements. For ...

The FDA issued a safety communication today warning of a potential increased risk of seizures tied to certain medications used to treat Parkinson's disease. The agency will require manufacturers of ...

Treatment with Crexont statistically significantly improved “On” time without troublesome dyskinesia compared with carbidopa/levodopa IR. The Food and Drug Administration (FDA) has approved Crexont ® ...

The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson's disease, Amneal Pharmaceuticals announced Wednesday. The treatment is a ...

The US Food and Drug Administration (FDA) has approved foscarbidopa and foslevodopa (Vyalev, AbbVie), a solution of carbidopa and levodopa prodrugs for 24-hour continuous subcutaneous infusion, for ...

The FDA approved Dhivy in November 2021 based upon bioavailability studies comparing Dhivy to an immediate-release tablet containing 25mg of carbidopa and 100mg of levodopa. Dhivy ™, a ...

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion for Onerji (levodopa/carbidopa, Tanabe Pharma) for the treatment of adults with ...